TB advocates
By
TB advocates
Published: Jan. 9, 2018, 9:20 p.m.·
Tags:
TB programs,
Diagnostics,
Access,
Advocacy
TB advocates urge the Kenyan government to overcome regulatory barriers to efficiently implement new TB and HIV diagnostic tools.
Read More →
By
TB advocates
Published: Jan. 9, 2018, 8:41 p.m.·
Tags:
Global TB response,
Advocacy
TB advocates call for a competitive selection process that gives full consideration to a range of candidates to identify an experienced, change-oriented leader.
Read More →
By
TB advocates
Published: Nov. 28, 2017, 1:35 a.m.·
Tags:
Treatment,
Access,
Advocacy
TB advocates urge the Romanian government to take immediate action to ensure availability of all TB treatment.
Read More →
By
TB advocates
Published: Sept. 16, 2017, 12:10 p.m.·
Tags:
Drug-resistant TB,
Treatment,
TB programs,
Access,
Advocacy
TB advocates urge the Indian government to develop a concrete plan for introducing delamanid.
Read More →
By
TB advocates,
TB CAB,
Treatment Action Group
Published: Aug. 16, 2017, 4:27 p.m.·
Tags:
Diagnostics,
HIV coinfection,
TB programs,
Access,
Advocacy
TB advocates urge the Kenyan Division of Leprosy, Tuberculosis and Lung Disease (DLTLD) to introduce a new, simple, and rapid TB test, TB LAM, which detects TB antigens in urine, and is an important tool for detecting TB in certain populations living with HIV.
Read More →
By
TB advocates
Published: April 19, 2017, 1:18 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Access,
Advocacy
TB advocates urge Otsuka to provide sufficient and sustainable access to delamanid for the treatment of drug-resistant TB in South Africa.
Read More →
By
TB advocates
Published: Feb. 23, 2017, 7:44 p.m.·
Tags:
Diagnostics,
HIV coinfection,
Advocacy
TB advocates urge PEPFAR to provide immediate access to the LAM test for TB diagnosis in HIV-positive people with advanced immunosuppression.
Read More →
By
TB advocates
Published: Feb. 22, 2017, 10:38 p.m.·
Tags:
Research and development,
Medicines,
Advocacy
TB advocates appeal to Sequella to act in the interest of public health and provide open access to all existing sutezolid data.
Read More →
By
civil society organizations,
TB advocates
Published: Feb. 1, 2017, 6:48 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Access,
Advocacy
Health groups call on the Indian Government to incorporate the life-saving TB drug delamanid into the Revised National TB Control Programme.
Read More →
By
TB advocates,
civil society organizations
Published: Jan. 16, 2017, 9:45 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Access,
Advocacy,
TB CAB
Advocates urge Prime Minister Modi to take immediate action to save a young woman, dying of XDR-TB and to roll out life-saving innovations to tackle the growing burden of drug-resistant TB in India.
Read More →
Page 3 of 5 · Total posts: 10
←First
2
3
4
Last→